Rocky Mountain MS Research Group
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Rocky Mountain MS Research Group sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Rocky Mountain MS Research Group: 4 sponsored US clinical trials, none currently recruiting.
Rocky Mountain MS Research Group sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 1 trials.
Upper-quartile sponsor footprint
Rocky Mountain MS Research Group sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS
NCT02965170
Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk
NCT02440126
Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation
NCT02217982
Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
NCT01945359
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the Rocky Mountain MS Research Group archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Multiple Sclerosis (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Rocky Mountain MS Research Group: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Rocky Mountain MS Research Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Rocky Mountain MS Research Group page
4 registered trials is a research-attention snapshot, not an endorsement of Rocky Mountain MS Research Group or any single study.
- None of Rocky Mountain MS Research Group's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Multiple Sclerosis is the condition Rocky Mountain MS Research Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rocky Mountain MS Research Group pipeline card: 4 registered trials from official public datasets.Report a data error.